Stock Analysis on Net
Stock Analysis on Net

Johnson & Johnson (NYSE:JNJ)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 

Johnson & Johnson, common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 29, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Loans and notes payable 3.32 2.06 6.82 2.07 1.50
Accounts payable 5.73 5.75 6.25 6.07 5.43
Accrued liabilities 4.75 6.09 6.11 7.48 7.99
Accrued rebates, returns and promotions 9.76 9.55 7.69 6.64 6.58
Accrued compensation and employee related obligations 2.29 2.38 1.78 1.97 1.99
Accrued taxes on income 2.09 1.79 1.14 0.61 0.80
Current liabilities 27.94% 27.62% 29.78% 24.85% 24.30%
Long-term debt, excluding current portion 17.02 15.45 14.35 16.47 18.66
Deferred taxes on income 1.36 1.91 3.40 4.11 4.12
Employee related obligations 4.03 4.27 3.61 4.89 6.16
Long-term taxes payable 0.22 1.72 2.30 3.14 3.75
Other liabilities 9.74 8.00 5.57 5.87 6.83
Non-current liabilities 32.37% 31.33% 29.23% 34.49% 39.52%
Total liabilities 60.31% 58.96% 59.01% 59.33% 63.82%
Preferred stock, without par value, unissued 0.00 0.00 0.00 0.00 0.00
Common stock, par value $1.00 per share 1.73 1.86 1.67 1.71 1.78
Accumulated other comprehensive loss -6.52 -7.48 -6.92 -7.17 -8.71
Retained earnings and Additional-paid-in-capital 86.50 91.81 68.50 67.61 65.12
Common stock held in treasury, at cost -42.02 -45.16 -22.25 -21.48 -22.01
Shareholders’ equity 39.69% 41.04% 40.99% 40.67% 36.18%
Total liabilities and shareholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Johnson & Johnson current liabilities as a percentage of total liabilities and shareholders’ equity decreased from 2022 to 2023 but then slightly increased from 2023 to 2024.
Non-current liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Johnson & Johnson non-current liabilities as a percentage of total liabilities and shareholders’ equity increased from 2022 to 2023 and from 2023 to 2024.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Johnson & Johnson total liabilities as a percentage of total liabilities and shareholders’ equity decreased from 2022 to 2023 but then increased from 2023 to 2024 exceeding 2022 level.
Shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Johnson & Johnson shareholders’ equity as a percentage of total liabilities and shareholders’ equity increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.